Shanmuga Hos.

Market Cap: Micro Cap
Industry: Hospital
ISIN: INE0TD301017
NSEID:
BSEID: 544365

INR

46.00

0.00 (0.00%)

BSENSE

Dec 30

BSE+NSE Vol: 8000

{
  "main_header": {
    "sid": 10039550,
    "name": "Shanmuga Hos.",
    "stock_name": "Shanmuga Hos.",
    "full_name": "Shanmuga Hospital Ltd",
    "name_url": "stocks-analysis/shanmuga-hos",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "46.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "46.00",
    "mcapval": "65.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544365,
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0TD301017",
    "curr_date": "Dec 30",
    "curr_time": "",
    "bse_nse_vol": 8000,
    "exc_status": "Active",
    "traded_date": "Dec 30, 2025",
    "traded_date_str": "2025 12 30",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shanmuga-hos-10039550-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Shanmuga Hos. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-shanmuga-hos-overvalued-or-undervalued-3747898",
        "imagepath": "",
        "date": "2025-12-05 08:44:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Shanmuga Hospitals’ Valuation Metrics</strong></p>\n<p>At a price-to-earnings (PE) ratio of approximately 15.6, Shanmuga Hospitals trades at a moderate multiple relative to many of its healthcare peers. The price-to-book value stands at 1.58, indicating the market values the company at nearly one and a half times its net asset value. Enterprise value (EV) multiples such as EV to EBIT and EV to EBITDA are 11.8 and 8.7 respectively, suggesting a balanced valuation when considering earnings before interest, taxes, depreciation, and amortisation.</p>\n<p>Return on capital employed (ROCE) and return on equity (ROE) are 12.75% and 10.09% respectively, reflecting decent profitability and efficient capital utilisation. However, the PEG ratio is reported as zero, which may indicate either..."
      },
      {
        "title": "Is Shanmuga Hos. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-shanmuga-hos-overvalued-or-undervalued-3716826",
        "imagepath": "",
        "date": "2025-11-20 08:08:34",
        "description": "As of 19 November 2025, the valuation grade for Shanmuga Hospitals has moved from very attractive to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios include a PE ratio of 14.42, an EV to EBITDA of 8.10, and a ROCE of 12.75%. \n\nIn comparison to its peers, Shanmuga Hospitals' PE ratio is significantly lower than that of Max Healthcare, which stands at 80.06, and also lower than Apollo Hospitals at 64.09. This suggests that while Shanmuga is overvalued, it is still more attractively priced than some of its competitors. Despite a recent one-week stock return of 4.57% compared to the Sensex's 0.85%, the overall valuation metrics indicate that investors should approach Shanmuga Hospitals with caution...."
      },
      {
        "title": "How has been the historical performance of Shanmuga Hos.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-shanmuga-hos-3695900",
        "imagepath": "",
        "date": "2025-11-13 00:44:41",
        "description": "Answer:\nThe historical performance of Shanmuga Hos. shows a steady increase in net sales over the past three years, rising from 39.34 Cr in Mar'23 to 43.04 Cr in Mar'24, and reaching 47.85 Cr in Mar'25. The total operating income mirrored this trend, with a consistent increase to 47.85 Cr in Mar'25. However, the operating profit (PBDIT) has seen a slight decline from 8.95 Cr in Mar'24 to 8.47 Cr in Mar'25, despite an increase in other income. Profit before tax also decreased from 7.02 Cr in Mar'24 to 5.69 Cr in Mar'25, leading to a profit after tax of 4.21 Cr in Mar'25, down from 5.25 Cr in Mar'24. The earnings per share (EPS) reflected this decline, dropping to 3.09 in Mar'25 from 5.36 in Mar'24. On the balance sheet, total assets increased significantly from 33.92 Cr in Mar'24 to 52.78 Cr in Mar'25, driven by a rise in cash and bank balances and total reserves. Total liabilities also rose, but at a slower..."
      },
      {
        "title": "Why is Shanmuga Hos. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shanmuga-hos-fallingrising-3663227",
        "imagepath": "",
        "date": "2025-11-01 00:05:46",
        "description": "As of 31-Oct, Shanmuga Hospital Ltd's stock price is currently at Rs 42.75, reflecting a decline of Rs 1.25, or 2.84%. The stock has underperformed its sector by 1.57% today, and it has experienced erratic trading, not trading on one day out of the last 20. The stock touched an intraday low of Rs 41.51, marking a decrease of 5.66%. Additionally, the delivery volume has significantly dropped by 58.33% compared to the 5-day average, indicating falling investor participation. The stock's performance over the past week shows a decline of 5.48%, while it has decreased by 6.06% over the past month, contrasting with the Sensex, which has gained 3.65% in the same period.\n\nIn the broader market context, Shanmuga Hospital Ltd's recent performance has been notably weaker than the benchmark, as it has seen a significant drop in both short-term and monthly returns compared to the Sensex. The Sensex has shown resilience ..."
      }
    ],
    "total": 73,
    "sid": "10039550",
    "stock_news_url": "https://www.marketsmojo.com/news/shanmuga-hospital-10039550"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "28-Nov-2025",
      "details": "Investor Presentation under Regulation 30 read with Schedule III of SEBI(LODR) 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "28-Nov-2025",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.",
      "datetime": "12-Nov-2025",
      "details": "Unaudited Financial Results For the Half Year Ended 30th September 2025 Together with the Limited review report.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Shanmuga Hos. overvalued or undervalued?

2025-12-05 08:44:32

Understanding Shanmuga Hospitals’ Valuation Metrics

At a price-to-earnings (PE) ratio of approximately 15.6, Shanmuga Hospitals trades at a moderate multiple relative to many of its healthcare peers. The price-to-book value stands at 1.58, indicating the market values the company at nearly one and a half times its net asset value. Enterprise value (EV) multiples such as EV to EBIT and EV to EBITDA are 11.8 and 8.7 respectively, suggesting a balanced valuation when considering earnings before interest, taxes, depreciation, and amortisation.

Return on capital employed (ROCE) and return on equity (ROE) are 12.75% and 10.09% respectively, reflecting decent profitability and efficient capital utilisation. However, the PEG ratio is reported as zero, which may indicate either...

Is Shanmuga Hos. overvalued or undervalued?

2025-11-20 08:08:34

As of 19 November 2025, the valuation grade for Shanmuga Hospitals has moved from very attractive to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios include a PE ratio of 14.42, an EV to EBITDA of 8.10, and a ROCE of 12.75%. In comparison to its peers, Shanmuga Hospitals' PE ratio is significantly lower than that of Max Healthcare, which stands at 80.06, and also lower than Apollo Hospitals at 64.09. This suggests that while Shanmuga is overvalued, it is still more attractively priced than some of its competitors. Despite a recent one-week stock return of 4.57% compared to the Sensex's 0.85%, the overall valuation metrics indicate that investors should approach Shanmuga Hospitals with caution....

How has been the historical performance of Shanmuga Hos.?

2025-11-13 00:44:41

Answer: The historical performance of Shanmuga Hos. shows a steady increase in net sales over the past three years, rising from 39.34 Cr in Mar'23 to 43.04 Cr in Mar'24, and reaching 47.85 Cr in Mar'25. The total operating income mirrored this trend, with a consistent increase to 47.85 Cr in Mar'25. However, the operating profit (PBDIT) has seen a slight decline from 8.95 Cr in Mar'24 to 8.47 Cr in Mar'25, despite an increase in other income. Profit before tax also decreased from 7.02 Cr in Mar'24 to 5.69 Cr in Mar'25, leading to a profit after tax of 4.21 Cr in Mar'25, down from 5.25 Cr in Mar'24. The earnings per share (EPS) reflected this decline, dropping to 3.09 in Mar'25 from 5.36 in Mar'24. On the balance sheet, total assets increased significantly from 33.92 Cr in Mar'24 to 52.78 Cr in Mar'25, driven by a rise in cash and bank balances and total reserves. Total liabilities also rose, but at a slower...

Why is Shanmuga Hos. falling/rising?

2025-11-01 00:05:46

As of 31-Oct, Shanmuga Hospital Ltd's stock price is currently at Rs 42.75, reflecting a decline of Rs 1.25, or 2.84%. The stock has underperformed its sector by 1.57% today, and it has experienced erratic trading, not trading on one day out of the last 20. The stock touched an intraday low of Rs 41.51, marking a decrease of 5.66%. Additionally, the delivery volume has significantly dropped by 58.33% compared to the 5-day average, indicating falling investor participation. The stock's performance over the past week shows a decline of 5.48%, while it has decreased by 6.06% over the past month, contrasting with the Sensex, which has gained 3.65% in the same period. In the broader market context, Shanmuga Hospital Ltd's recent performance has been notably weaker than the benchmark, as it has seen a significant drop in both short-term and monthly returns compared to the Sensex. The Sensex has shown resilience ...

View All News